Skip to main content
BioInfra Life Science Inc. logo

BioInfra Life Science Inc. — Investor Relations & Filings

Ticker · 266470 ISIN · KR7266470004 KO Professional, scientific and technical activities
Open in API
Filings indexed 121 across all filing types
Latest filing 2024-08-22 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 266470

About BioInfra Life Science Inc.

http://bioinfra.co.kr/?lang=en

BioInfra Life Science Inc. is a biotechnology company focused on cancer prevention, early detection, and treatment. The company's core technology is a multi-biomarker blood test, an in-vitro diagnostic solution designed for the early screening of eight major cancers, including lung, liver, stomach, colorectal, prostate, breast, pancreatic, and ovarian cancer. This test analyzes cancer risk from a small blood sample. In addition to its diagnostic platform, the company develops cancer gene treatments and technologies to monitor the potential for metastasis and recurrence, aiming to provide innovative solutions in the healthcare field.

Recent filings

Filing Released Lang Actions
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from a Korean company, specifically detailing a 'Capital Increase Decision' (유상증자결정). This document outlines the issuance of new shares, the purpose of the capital raise, the third-party allocation details, and the impact on shareholding structure. In the context of financial filings, announcements regarding new share issues, capital changes, or capital structure adjustments are classified as 'Share Issue/Capital Change'.
2024-08-22 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회 결과' (Annual General Meeting Results) and provides the official outcomes of the shareholder meeting held on March 28, 2024, including the approval of financial statements, director compensation, and auditor reports. This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2024-03-28 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal submission of an audit report ('감사보고서 제출') by Bioinfra Life Science. It contains key financial data, the auditor's opinion, and confirmation of the audit report receipt date. While it provides summary financial information, it is a regulatory filing specifically notifying the market of the audit report's submission, which fits the 'Audit Report / Information' (AR) category as it pertains to the results of the audit process. FY 2023
2024-03-20 Korean
사업보고서 (2023.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the fiscal year 2023 (2023.01.01-2023.12.01) submitted to the Financial Services Commission and the Korea Exchange. In the context of Korean corporate filings, the 'Business Report' (사업보고서) is the equivalent of the US 10-K, serving as the comprehensive annual report containing financial statements, business operations, and governance details. Given the document length and content, it is classified as a 10-K. FY 2023
2024-03-20 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Bioinfra Life Science. It contains the agenda for the upcoming Annual General Meeting (AGM), including the approval of financial statements, director remuneration, and auditor remuneration. It also provides management's business overview and financial statements as reference materials for shareholders. This document is a standard proxy solicitation and information statement provided to shareholders prior to an AGM.
2024-03-13 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의) issued by Bioinfra Life Science. It outlines the date, location, and agenda items (such as approval of financial statements and director compensation) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation or notice of meeting, which falls under the Proxy Solicitation & Information Statement category.
2024-02-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.